Prognostic significance of the SIRI in gastrointestinal malignancy patients: a pooled analysis of 10091 participants - supplementary material

PRISMA 2020 Checklist Table S1. Quality assessment of included studies. Table S2. Meta-regression analyses for the association of confounding factors and the hazard ratio for OS and DFS. Figure S1. The flowchart of study selection. Figure S2. Sensitivity analyses for OS (A) and DFS (B) between the high SIRI and low SIRI groups in GI malignancies Figure S3. Begg’s funnel plots for OS (A) and DFS (B) between the high SIRI and low SIRI groups in GI malignancies.